Teeth were removed with a curved mosquito forceps and sockets were closed with 5-0 nylon thread sutures using non-traumatic needles (Mononylon, Ethicon, São José dos Campos, SP, Brazil). Control rats underwent a sham operation, which aimed to maintain maximum jaw opening for 10 min under anaesthesia. To detect signs of malnutrition that could presumably selleck inhibitor affect growth, animals’ body weight was registered at inception and weekly during the study period. All animals were sacrificed with an overdose of sodium pentobarbital (60 mg/kg; intraperitoneal injection) 8 weeks after tooth extraction (13 weeks old). The right TMJ of all groups and the left TMJ of the unilateral extraction group were prepared

for immunohistochemical analysis. Immediately after death, the heads were fixed in 10% paraformaldehyde for 3 days, and then decalcified in 10% EDTA (ethylenediamine tetraacetic acid) for 30 days. After that, the heads were carefully dissected along the middle sagittal plane into two halves and tissues were removed until Vemurafenib cell line the areas surrounding the temporomandibular condyle were exposed. Any excess tissues were removed and specimens were embedded in paraffin with the ramus parallel to the surface of the block. Serial sections of 5 μm were cut through the TMJ at the parasagittal plane using a rotary microtome (Leica RM 2155) and mounted on TESPA-coated glass slides (Sigma–Aldrich,

St Louis, MO, USA). Sections were left to dry. Sections were submerged in 3% H2O2 for 10 min to block endogenous peroxidase activity. After washing, sections were incubated with Proteinase K (10 μg/ml, Sigma, MO, USA) for 30 min at 37 °C for protease digestion. Chlormezanone Sections were then washed and incubated in normal blocking serum (sc-2023, Santa Cruz Biotechnology, California, USA) for 30 min, followed by incubation with primary goat anti-IL-1β antibody (M-20, Santa Cruz Biotechnology), anti-type II collagen antibody (C-19, Santa Cruz Biotechnology, California, USA) or anti-VEGF antibody (A-20, Santa Cruz Biotechnology, California, USA), overnight under 4 °C. After washing, sections were incubated with

biotinylated secondary antibody (sc-2023, Santa Cruz Biotechnology, California, USA) for 30 min at 37 °C, followed again by washing. AB enzyme reagent (sc-2023, Santa Cruz Biotechnology, California, USA) was applied for 1 h at 37 °C and washed with 1× TBS plus 0.1% Tween-20 before dipping in 3,3-diaminobenzidine tetrahydrochloride (DAB, Sigma-Aldrich, St Louis, MO, USA) for 5 min to identify the binding sites. Brown staining indicated positive binding. Sections were then counterstained with Mayer Haematoxylin for background staining. In order to evaluate for non-specific binding, substitution of the primary antibody with blocking serum (sc-2023, Santa Cruz Biotechnology, California, USA) was performed as negative control.